Report Categories
View AllRecent Articles
View All
MYGN Myriad Genetics Q1 earnings miss by 289 percent as EPS decline overshadows flat revenue performance
John Wiley WLY Stock Is It Underpriced John Wiley posts 117 percent EPS beat topping analyst estimates
OLB The OLB delivers narrower Q4 2025 loss than forecasts drops 897 percent in todays trading
WHWK Whitehawk Therapeutics reports far wider than expected Q4 2025 loss with shares edging 05 lower today